Q1 2026 saw strong revenue and EBITDA growth, margin expansion, and improved cash flow, driven by diagnostics, premium, and home care segments. Leverage and CapEx were reduced, with investments focused on technology and efficiency. Premium and B2B channels remain key growth drivers.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.